136 related articles for article (PubMed ID: 25191940)
21. Angiogenesis inhibitors identified by cell-based high-throughput screening: synthesis, structure-activity relationships and biological evaluation of 3-[(E)-styryl]benzamides that specifically inhibit endothelial cell proliferation.
Hada K; Suda A; Asoh K; Tsukuda T; Hasegawa M; Sato Y; Ogawa K; Kuramoto S; Aoki Y; Shimma N; Ishikawa T; Koyano H
Bioorg Med Chem; 2012 Feb; 20(4):1442-60. PubMed ID: 22269278
[TBL] [Abstract][Full Text] [Related]
22. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε.
Yang Y; Xu T; Zhang Y; Qin X
Cell Signal; 2017 Feb; 31():58-65. PubMed ID: 28057520
[TBL] [Abstract][Full Text] [Related]
24. Kinase and GPCR polypharmacological approach for the identification of efficient anticancer medicines.
Park H; Jung HY; Mah S; Kim K; Hong S
Org Biomol Chem; 2020 Oct; 18(41):8402-8413. PubMed ID: 33112339
[TBL] [Abstract][Full Text] [Related]
25. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Shallal HM; Russu WA
Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632
[TBL] [Abstract][Full Text] [Related]
26. Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3).
Lin WH; Hsu JT; Hsieh SY; Chen CT; Song JS; Yen SC; Hsu T; Lu CT; Chen CH; Chou LH; Yang YN; Chiu CH; Chen CP; Tseng YJ; Yen KJ; Yeh CF; Chao YS; Yeh TK; Jiaang WT
Bioorg Med Chem; 2013 Jun; 21(11):2856-67. PubMed ID: 23618709
[TBL] [Abstract][Full Text] [Related]
27. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.
Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S
Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670
[TBL] [Abstract][Full Text] [Related]
28. Structure-Based Development of Isoform-Selective Inhibitors of Casein Kinase 1ε vs Casein Kinase 1δ.
Choi JY; Noguchi Y; Alburger JM; Bayle S; Chung E; Grant W; Chaikuad A; Knapp S; Duckett DR; Roush WR
J Med Chem; 2023 Jun; 66(11):7162-7178. PubMed ID: 37204207
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase.
Li S; Yao Z; Zhao Y; Chen W; Wang H; Kuang X; Zhan W; Yao S; Yu S; Hu W
Bioorg Med Chem Lett; 2012 Aug; 22(16):5279-82. PubMed ID: 22789429
[TBL] [Abstract][Full Text] [Related]
30. Ligand-protein interactions of selective casein kinase 1δ inhibitors.
Mente S; Arnold E; Butler T; Chakrapani S; Chandrasekaran R; Cherry K; DiRico K; Doran A; Fisher K; Galatsis P; Green M; Hayward M; Humphrey J; Knafels J; Li J; Liu S; Marconi M; McDonald S; Ohren J; Paradis V; Sneed B; Walton K; Wager T
J Med Chem; 2013 Sep; 56(17):6819-28. PubMed ID: 23919824
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis and Biological Evaluation of Isoxazole-Based CK1 Inhibitors Modified with Chiral Pyrrolidine Scaffolds.
Luxenburger A; Schmidt D; Ianes C; Pichlo C; Krüger M; von Drathen T; Brunstein E; Gainsford GJ; Baumann U; Knippschild U; Peifer C
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832206
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents.
Yoshida M; Hayakawa I; Hayashi N; Agatsuma T; Oda Y; Tanzawa F; Iwasaki S; Koyama K; Furukawa H; Kurakata S; Sugano Y
Bioorg Med Chem Lett; 2005 Jul; 15(14):3328-32. PubMed ID: 15955697
[TBL] [Abstract][Full Text] [Related]
33. Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
Sinnberg T; Wang J; Sauer B; Schittek B
BMC Cancer; 2016 Aug; 16():594. PubMed ID: 27488834
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors.
Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL
Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588
[TBL] [Abstract][Full Text] [Related]
35. The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/epsilon.
Sugiyama Y; Hatano N; Sueyoshi N; Suetake I; Tajima S; Kinoshita E; Kinoshita-Kikuta E; Koike T; Kameshita I
Biochem J; 2010 Apr; 427(3):489-97. PubMed ID: 20192920
[TBL] [Abstract][Full Text] [Related]
36. DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R).
Liu JL; Gao GR; Zhang X; Cao SF; Guo CL; Wang X; Tong LJ; Ding J; Duan WH; Meng LH
J Pharmacol Exp Ther; 2014 Mar; 348(3):432-41. PubMed ID: 24361696
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.
N'gompaza-Diarra J; Bettayeb K; Gresh N; Meijer L; Oumata N
Eur J Med Chem; 2012 Oct; 56():210-6. PubMed ID: 22982525
[TBL] [Abstract][Full Text] [Related]
38. C5-Iminosugar modification of casein kinase 1δ lead 3-(4-fluorophenyl)-5-isopropyl-4-(pyridin-4-yl)isoxazole promotes enhanced inhibitor affinity and selectivity.
von Drathen T; Ure EM; Kirschner S; Roth A; Meier L; Woolhouse AD; Cameron SA; Knippschild U; Peifer C; Luxenburger A
Arch Pharm (Weinheim); 2022 May; 355(5):e2100497. PubMed ID: 35174898
[TBL] [Abstract][Full Text] [Related]
39. Chloromethylhalicyclamine B, a Marine-Derived Protein Kinase CK1δ/ε Inhibitor.
Esposito G; Bourguet-Kondracki ML; Mai LH; Longeon A; Teta R; Meijer L; Van Soest R; Mangoni A; Costantino V
J Nat Prod; 2016 Nov; 79(11):2953-2960. PubMed ID: 27933894
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis and anti-tumor activities of N-substituted benzamide derivatives].
Feng J; Xie P; Weng ZJ; Yan Z; Wang N; Li JQ
Yao Xue Xue Bao; 2009 Jun; 44(6):603-8. PubMed ID: 19806890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
